Pharmaco - Press Releases

Date	Title	Company
29-Apr-2022	Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union	Moderna, Inc.
29-Apr-2022	PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study	PureTech
29-Apr-2022	Immutep quarterly activities report and Appendix 4C	Immutep Limited
29-Apr-2022	Bone Therapeutics announces 2021 full year results	Bone Therapeutics
29-Apr-2022	Envirotainer is driving the shift to a more sustainable pharmaceutical cold chain	Envirotainer
29-Apr-2022	Weekly Life Science News Round Up: 25th – 29th April	PharmiWeb.Jobs
29-Apr-2022	Continued strategic progress and updated full year guidance following Custopharm acquisition	Hikma Pharmaceuticals PLC
29-Apr-2022	Santhera will Publish its 2021 Annual Report by June 3, 2022, and Hold its Annual General Meeting on June 29, 2022	Santhera
29-Apr-2022	New number of shares and votes in Moberg Pharma AB (publ)	Moberg Pharma AB
29-Apr-2022	Janssen Submits Marketing Authorisation Application to EMA Seeking Approval of Niraparib and Abiraterone Acetate Dual Action Tablet Plus Prednisone for the Treatment of Patients with HRR Gene-Mutated Metastatic Castration Resistant Prostate Cancer	Janssen Pharmaceutical Companies of Johnson & Johnson
29-Apr-2022	ESG Report 2021: SYNLAB defines high-impact areas to drive its ambitious environmental, social and governance agenda	SYNLAB AG
28-Apr-2022	Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022	MorphoSys AG
28-Apr-2022	Zur Rose Group AG: Shareholders approve all proposals	Zur Rose Group AG
28-Apr-2022	Abivax publishes Universal Registration Document 2022 'Document d'Enregistrement Universel'	ABIVAX
28-Apr-2022	AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved	AEVIS VICTORIA SA
28-Apr-2022	Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1	Sanofi
28-Apr-2022	Solvay and Carbios demonstrate enzymatic depolymerization in PET/PVDC barrier film	Solvay and Carbios
28-Apr-2022	Immutep to announce new TACTI-002 data in an oral presentation at the ASCO 2022 Annual Meeting	Immutep Limited
28-Apr-2022	OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases	OMass Therapeutics
28-Apr-2022	EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa	EVERSANA